Vetoquinol Sa operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other
pharmaceutical manufacturers in Europe:
Dechra Pharmaceuticals PLC
of the United Kingdom
sales of £407.10 million [US$524.61 million]
of which 64%
was European Pharmaceuticals),
(206.70 million Euro [US$234.09 million]
Dottikon ES Holding AG
based in Switzerland
(158.23 million Swiss Francs [US$157.13 million]
of which 91%
was Pharma Products).
During the year ended December of 2018, sales at
Vetoquinol Sa were 367.90 million Euro (US$416.65 million).
increase of 4.5%
versus 2017, when the company's sales were 352.17 million Euro.
This was the fifth consecutive year of sales increases at Vetoquinol Sa
(and since 2013, sales have increased a total of 23%).